Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani

被引:118
作者
Mukherjee, Angana
Padmanabhan, Prasad K.
Singh, Sushma
Roy, Gaetan
Girard, Isabelle
Chatterjee, Mitali
Ouellette, Marc
Madhubala, Rentala [1 ]
机构
[1] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India
[2] Univ Laval, Fac Med, Ctr Rech & Infectol, Ctr Rech CHUL, Quebec City, PQ G1K 7P4, Canada
[3] Univ Laval, Fac Med, Dept Microbiol, Quebec City, PQ G1K 7P4, Canada
[4] Inst Postgrad Med Educ & Res, Dept Pharmacol, Kolkata 70002, W Bengal, India
基金
加拿大健康研究院;
关键词
drug resistance; sodium antimony gluconate; Leishmania donovani;
D O I
10.1093/jac/dkl494
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The resistance of clinical isolates of Leishmania donovani to sodium antimony gluconate (SAG), the mainstay of treatment in Indian visceral leishmaniasis, has become a critical issue in India. The present work investigates the mechanism of resistance to SAG in parasites isolated from patients who are unresponsive to SAG. Methods and results: Susceptibility to SAG as determined in vitro with intracellular amastigotes correlated well with the clinical response. The ABC transporter gene MRPA was amplified in resistant field isolates as part of an extrachromosomal circle. Co-amplification of the pterin reductase gene (PTR1) and MRPA suggests amplification of the H locus in SAG-resistant isolates. Amplification of MRPA was correlated to increased RNA as determined by real-time PCR. MRPA is an ABC-thiol transporter, and cysteine and glutathione were increased in the resistant isolates. Ornithine decarboxylase (a rate limiting enzyme in polyamine biosynthesis), and gamma-glutamylcysteine synthetase (a rate limiting enzyme in glutathione biosynthesis), the two building blocks of the main cellular thiol trypanothione, were over-expressed in some of the resistant isolates. Conclusions: A variety of resistance mechanisms to SAG, most of them consistent with a model based on the study of resistance in vitro, were present in clinical isolates from the same geographical region.
引用
收藏
页码:204 / 211
页数:8
相关论文
共 45 条
[41]   Novel mechanism of drug resistance in kala azar field isolates [J].
Singh, N ;
Singh, RT ;
Sundar, S .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (04) :600-607
[42]   Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic [J].
Sundar, S ;
More, DK ;
Singh, MK ;
Singh, VP ;
Sharma, S ;
Makharia, A ;
Kumar, PCK ;
Murray, HW .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :1104-1107
[43]  
WHITE TC, 1988, J BIOL CHEM, V263, P16977
[44]   Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani [J].
Wyllie, S ;
Cunningham, ML ;
Fairlamb, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (38) :39925-39932
[45]   Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug Pentostam [J].
Zhou, Y ;
Messier, N ;
Ouellette, M ;
Rosen, BP ;
Mukhopadhyay, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (36) :37445-37451